Ferring is interested in funding exploratory, basic, and clinical research grants to collect data and expand knowledge about the effects on SARS-CoV-2 on reproduction, pregnancy, and fetal/neonatal health.
Deadline: accepting applications on a rolling basis through October 31, 2020
Pioneering Ideas: Exploring the Future to Build a Culture of Health seeks proposals that are primed to influence health equity in the future. We are interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work.
Deadline: proposals accepted on a rolling basis
More information.
Kaggle is issuing a call to action to the world’s artificial intelligence experts to develop text and data mining tools that can help the medical community develop answers to high priority scientific questions. In response to the COVID-19 pandemic, the White House and a coalition of leading research groups have prepared the COVID-19 Open Research Dataset (CORD-19). The CORD-19 dataset represents the most extensive machine-readable coronavirus literature collection available for data mining to date.
This milestone-driven Funding Opportunity Announcement (FOA) invites applications for single-site clinical trials that: (1) address barriers that impede population-level implementation of case finding and cascade screening (i.e., blood relatives of FH index cases are systematically contacted based on their risk according to the pattern of inheritance); (2) explore implementation science methodologies to assess the uptake, cost-effectiveness, feasibility, and scalability of family-based cascade screening programs for familial hypercholesterolemia (FH); (3) develop or improve machine learning algorithms and data mining techniques to find high-risk individuals using electronic health records (EHRs); and (4) optimize treatment strategies and health outcomes.
Deadline: March 8, 2021
The goal of this Funding Opportunity Announcement (FOA) is to advance surveillance science by supporting the development of new and innovative tools and methods for more efficient, detailed, timely, and accurate data collection by cancer registries. Specifically, the FOA seeks applications for projects to develop, adapt, apply, scale-up, and validate tools and methods to improve the collection and integration cancer registry data and to expand the data items collected. Applications must be built on partnership with U.S. population-based central cancer registries (a partnership must involve at least two different registries). Tools and methods proposed for development are expected to enhance the registry core infrastructure and, in so doing, expand the usefulness of registry-collected data to support high-quality cancer research.
Deadline: November 18, 2020
The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Developmental Centers for AIDS Research (D-CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. D-CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. Additionally, D-CFARs provide support to assist investigators in the development of a competitive standard CFAR. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.
Please read the full program announcement before preparing your internal application.
A base of up to $1,000,000 total costs per center per year will be awarded. The scope of the proposed project should determine the project period. The maximum project period is 5 years.
D-CFAR-specific Eligibility Requirements
NIH HIV/AIDS Funded Research Base (FRB)
Institutions/Organizations with a HIV/AIDS FRB of $10M annually (minimum) are eligible to apply for a D-CFAR. The FRB is defined as the amount of Total Cost funding from NIH for one fiscal year (October 1 to September 30) preceding the calendar year of application submission. D-CFAR applicants must maintain the required minimum FRB during the year of submission in order to be funded at the requested amount. This applies only to competing applications. The NIH HIV/AIDS FRB is compiled from data provided by the NIH Office of AIDS Research to determine eligibility. Applicants can request the FRB from NIAID.
The FRB includes NIH peer-reviewed HIV/AIDS research grants, program projects, and cooperative agreements utilizing the following mechanisms only: DP1, DP2, DP5, R00, R01, R03, R15, R21, R24, R33, R34, R35, R36, R37, R56, R61, RF1, SC1, SC2, SC3, U01, U10, U19, U24, U34, UH2, UH3, UG3, and K series awards. On a case-by-case basis, the following mechanisms will be considered based on whether or not the award involves primarily research activity: KL1, KL2, N01, P01, P50, PM1, U54, UG1, UM1, UM2 and RC series grants. Excluded from the NIH HIV/AIDS FRB are all funds from any source other than NIH. Additionally, only the amount budgeted directly to an applicant institution(s) will be included for grants over $5M in the FRB.
Multi-institutional D-CFAR applications may combine the NIH HIV/AIDS-funded research of all the investigators at the institutions participating in the proposed D-CFAR to meet the NIH HIV/AIDS FRB eligibility. A D-CFAR applicant cannot use the FRB of an institution that is already part of another CFAR or D-CFAR. D-CFARs that use a distant institution for a core facility may not use the funded research of that institution if they are not including all of the NIH HIV/AIDS investigators at that institution as part of the D-CFAR.
One D-CFAR award per institution
No institution may have more than one D-CFAR or CFAR award concurrently. An institution that is part of a multi-institutional D-CFAR or CFAR application or award may not be listed as a multi-institutional participant in a D-CFAR application. Independent campuses that are part of a large multiple city university are considered to be separate institutions, and each may submit one application.
Multi-institutional D-CFAR
In some cases, two or more institutions that can demonstrate a credible plan for collaborative research networks using D-CFAR Cores may wish to submit an application for a single D-CFAR award. A multi-institutional D-CFAR application must designate a lead institution that will receive the award, should demonstrate sharing in leadership positions, and provide details of agreements regarding coordination and support of Cores and activities at other participating institutions.
Cores outside of the D-CFAR institution
With appropriate justification, D-CFAR awards may support a core at an institution that is not part of the D-CFAR, including a primate facility or a foreign institution that provides a unique resource such as a clinical and/or laboratory site.
Detailed selection criteria can be found under Section V. Application Review Information in the solicitation.
An Institution may submit 1 proposal.
If you are interested in submitting for this program, you must first submit an internal application to limsub@uga.eduaccording to the required instructions below.
Limited Submission announcements often generate multiple competing proposals. UGA reviewers judge proposals as they would in any peer review process, so PIs are urged to put their best foot forward. Along with typical criteria, reviewers will evaluate internal proposals based on their fit with the sponsor’s articulated goals and criteria.
The above internal application materials should be submitted via email as a single .PDF file to limsub@uga.edu by the internal deadline listed above.
Please submit questions regarding the internal competition to limsub@uga.edu.
For questions directly related to this program, please contact the following program officers:
Candice Beaubien, M.P.H.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3098
Email: candice.beaubien@nih.gov
Geraldina Dominguez, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-781-3291
Email: domingug@mail.nih.gov
Shimian Zou, Ph.D.
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-435-0074
Email: shimian.zou@nih.gov
Basil A. Eldadah, M.D., Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-6761
Email: eldadahb@nia.nih.gov
Denise A. Russo, Ph.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6871
Email: drusso1@mail.nih.gov
Darien Weatherspoon, D.D.S., M.P.H.
National Institute of Dental and Craniofacial Research (NIDCR)
(301) 594-5394
darien.weatherspoon@nih.gov
Peter J. Perrin, Ph.D.
National Institute of Diabetes and Digestive Kidney Diseases (NIDDK)
Telephone: 301-451-3759
Email: Peter.Perrin@nih.gov
Vasundhara Varthakavi, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-2146
Email: Varthakaviv@nida.nih.gov
Christopher Gordon, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-1613
Email: cg206o@nih.gov
Rebecca Henry, Ph.D., B.S.N., R.N.
National Institute of Nursing Research (NINR)
Telephone: 301-594-5976
Email: rebecca.henry@nih.gov
Rick Berzon, Dr.P.H., P.A.
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-8949
Email: rick.berzon@nih.gov
Geetha Bansal, Ph.D.
Fogarty International Center (FIC)
Telephone: 301-496-1492
Email: geetha.bansal@nih.gov
View our calendar for all Current and Closed Limited Submissions.
Subscribe to our listerv to receive weekly internal competition announcements.
What is a Limited Submission?
The mission of the Foundation is to support early stage investigators engaged in basic biomedical research that has the potential to significantly advance the understanding, diagnosis or treatment of disease. The funds are designed to provide faculty members with support to move the project forward to the point where R01 or other independent funding can be obtained.
Grants are competitively provided to investigators based on their proposals, selected from applicants on an annual basis. Applicants should be in the first to fourth year of their tenure track faculty position and not have current R01 funding. Grants are usually $60,000 and funding commences on October 1.
Please read the full program announcement linked above before preparing your internal application.
The regular grants provide $60,000 per year for a period of up to three years. The grants are not renewable. The Foundation will not fund overhead. Grants will be made and restricted to domestic institutions. Funding for years 2 and 3 is contingent upon approval of a yearly progress report by the applicant submitted via e-mail. These are generally one page summaries of the work in progress. Failure to submit progress reports jeopardizes subsequent funding. A grant is made on the assumption that the recipient will use the funds for the purposes indicated in the applications and in the same institution. If the recipient moves to another institution during the term of the grant, payments may or may not be continued, depending upon reconsideration by the Trustees of the Foundation upon receipt of a written request and justification for transfer of funds. Unexpended funds will be returned to the Foundation at the end of the year for which a grant has been made, unless an extension is requested and justified and approved by the Trustees in writing.
An Institution may submit one proposal.
If you are interested in submitting for this program, you must first submit an internal application to limsub@uga.eduaccording to the required instructions below.
Limited Submission announcements often generate multiple competing proposals. UGA reviewers judge proposals as they would in any peer review process, so PIs are urged to put their best foot forward. Along with typical criteria, reviewers will evaluate internal proposals based on their fit with the sponsor’s articulated goals and criteria.
The above internal application materials should be submitted via email as a single .PDF file to limsub@uga.edu by 11:59pm on the internal deadline listed above.
Please submit questions regarding the internal competition to limsub@uga.edu.
For questions directly related to this program, please contact the following program officer:
View our calendar for all Current and Closed Limited Submissions.
Subscribe to our listerv to receive weekly internal competition announcements.
What is a Limited Submission?
Mozilla is announcing today the creation of a COVID-19 Solutions Fund as part of the Mozilla Open Source Support Program (MOSS). Through this fund, we will provide awards of up to $50,000 each to open source technology projects which are responding to the COVID-19 pandemic in some way.
The multi-agency Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases. The central theme of submitted projects must be the quantitative or computational understanding of pathogen transmission dynamics. The intent is discovery of principles of infectious disease transmission and testing mathematical or computational models that elucidate infectious disease systems.
Deadline: November 18, 2020
Emergent Ventures invites applications from scientists at academic institutions currently working on a COVID-19 related project and in need of funding. Fast Grants are $10,000 to $500,000 and decisions are made in under 48 hours. EV requires that a Fast Grant be used solely to expedite COVID-19-related science. Beyond that, the grant recipient has complete discretion over how it is spent.
